Cleared Traditional

K844284 - COPAL DIGITAL SPHYGMOMANOMETER UA-540

K844284 is an FDA 510(k) clearance for COPAL DIGITAL SPHYGMOMANOMETER UA-540, manufactured by Takeda Medical, Inc.. The device is a Class 2 Cardiovascular device with product code DXN cleared through the Traditional 510(k) pathway after a 95-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1985
Decision
95d
Days
Class 2
Risk

K844284 is an FDA 510(k) clearance for the COPAL DIGITAL SPHYGMOMANOMETER UA-540. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Takeda Medical, Inc. (Irvine, US). The FDA issued a Cleared decision on February 8, 1985 after a review of 95 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Takeda Medical, Inc. devices

FDA 510(k) Submission Details - K844284

510(k) Number K844284 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 05, 1984
Decision Date February 08, 1985
Days to Decision 95 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
30d faster than avg
Panel avg: 125d · This submission: 95d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXN Device Classification - Class 2, Special Controls

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 920
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K844284.
DINAMAP VITAL SIGNS MONITOR 1846 SX & 1846P SX
K844839 · Critikon Company, LLC · Apr 1985
CALCULATING CUFF INFLATOR TD312
K842067 · D. E. Hokanson, Inc. · Mar 1985
ACCUTORR CSM SYSTEM
K842538 · Datascope Corp. · Mar 1985
MUSE-DP
K840932 · Marquette Electronics, Inc. · Oct 1984
NON-INVASIVE BP MODULE 7000
K841336 · Marquette Electronics, Inc. · Oct 1984
AUTOMATED NON-INVASIVE PRESSURE MODULE
K840909 · Gould, Inc. · Jun 1984